查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1702177

2025 年至 2033 年 COPD 和氣喘設備市場報告（按產品（吸入器、霧化器）、適應症（氣喘、COPD）、配銷通路（零售藥局、醫院、線上藥局）和地區分類）

COPD and Asthma Devices Market Report by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Channel (Retail Pharmacies, Hospitals, Online Pharmacies), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球 COPD 和氣喘設備市場規模達 478 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 705 億美元，2025-2033 年期間的成長率 (CAGR) 為 4.42%。市場成長主要得益於具有即時監控功能的智慧吸入器技術的不斷進步、呼吸系統疾病的日益流行、對個人化治療方案的重視程度的提高（以實現更準確的藥物輸送）以及由於醫療保健服務的改善而導致的新興市場需求的不斷成長。

慢性阻塞性肺病 (COPD) 是一種導致肺部氣流受阻的發炎性疾病。其早期症狀包括呼吸短促、喘息、胸悶、伴隨或不伴隨黏液的慢性咳嗽、常感冒和喉嚨痛。另一方面，氣喘（也稱為支氣管氣喘）是一種影響肺部氣道的呼吸系統疾病。其症狀為呼吸短促、胸悶、睡眠困難、咳嗽或喘息。這些呼吸系統疾病可以透過各種有助於輸送吸入藥物的設備來治療。 COPD 和氣喘裝置，也稱為肺部藥物輸送裝置，用於呼吸系統疾病的永久治療或搶救療法。因此，它們在全球範圍內獲得了巨大的吸引力。

COPD 與氣喘設備市場趨勢：

全球老年人口不斷成長，極易患慢性呼吸系統疾病，這是對市場產生正面影響的關鍵因素之一。此外，由於吸菸率上升導致呼吸系統疾病發生率上升，也增加了慢性阻塞性肺病和氣喘設備的銷售量。除此之外，醫療保健支出的增加和醫療保健產業的持續自動化也促進了市場的成長。先進醫療解決方案的廣泛採用為全球製造商提供了豐厚的成長機會。目前，醫療保健從業者和肺部疾病專家更喜歡藥物和設備的組合，因為它們具有快速有效的效果。此外，化學工業的擴張導致環境污染污染程度和呼吸問題的加劇，進而推動了市場的發展。此外，攜帶式藥物輸送設備的引入正在推動市場成長。

本報告回答的關鍵問題

  • 2024 年全球 COPD 和氣喘設備市場規模？ 2025 年至 2033 年期間全球 COPD 和氣喘設備市場的預期成長率為何？
  • 推動全球 COPD 和氣喘設備市場發展的關鍵因素有哪些？
  • COVID-19 對全球 COPD 和氣喘設備市場有何影響？
  • 根據產品，全球 COPD 和氣喘設備市場是如何分佈的？
  • 根據適應症，全球 COPD 和氣喘設備市場如何分佈？
  • 根據配銷通路，全球 COPD 和氣喘設備市場分佈如何？
  • 全球 COPD 和氣喘設備市場的主要區域有哪些？
  • 全球 COPD 和氣喘設備市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球 COPD 與氣喘設備市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 吸入器
    • 關鍵部分
      • 藥物粉狀吸入器（DPI）
      • 定量吸入器（MDI）
      • 軟霧吸入器
  • 霧化器
    • 關鍵部分
      • 壓縮機霧化器
      • 超音波霧化器
      • 網狀霧化器

第7章：市場區隔：依指標

  • 氣喘
  • 慢性阻塞性肺病

第8章：市場區隔：按配銷通路

  • 零售藥局
  • 醫院
  • 網路藥局

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Adherium Limited
    • Aristopharma Ltd.
    • AstraZeneca PLC
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Cohero Health Inc.
    • Koninklijke Philips NV
    • Omron Corporation
    • Pari Respiratory Equipment Inc.
    • Recipharm AB
    • Verona Pharma plc
Product Code: SR112025A6126

The global COPD and asthma devices market size reached USD 47.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 70.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.42% during 2025-2033. The market growth is primarily driven by continual technological advancements in smart inhalers with real-time monitoring capabilities, growing prevalence of respiratory conditions, an enhanced emphasis on personalized treatment options for more accurate drug delivery and increasing demand in emerging markets due to improved healthcare access.

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.

COPD and Asthma Devices Market Trends:

The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices. Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth. The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome. Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.

Key Market Segmentation:

Breakup by Product:

  • Inhalers
  • Drug Powdered Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Soft Mist Inhalers
  • Nebulizers
  • Compressor Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

Breakup by Indication:

  • Asthma
  • COPD

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospitals
  • Online Pharmacies

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.

Key Questions Answered in This Report

  • 1.What was the size of the global COPD and asthma devices market market in 2024?
  • 2.What is the expected growth rate of the global COPD and asthma devices market during 2025-2033?
  • 3.What are the key factors driving the global COPD and asthma devices market?
  • 4.What has been the impact of COVID-19 on the global COPD and asthma devices market?
  • 5.What is the breakup of the global COPD and asthma devices market based on the product?
  • 6.What is the breakup of the global COPD and asthma devices market based on the indication?
  • 7.What is the breakup of the global COPD and asthma devices market based on distribution channel?
  • 8.What are the key regions in the global COPD and asthma devices market?
  • 9.Who are the key players/companies in the global COPD and asthma devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global COPD and Asthma Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Drug Powdered Inhalers (DPIs)
      • 6.1.2.2 Metered Dose Inhalers (MDIs)
      • 6.1.2.3 Soft Mist Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Nebulizers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Compressor Nebulizers
      • 6.2.2.2 Ultrasonic Nebulizers
      • 6.2.2.3 Mesh Nebulizers
    • 6.2.3 Market Forecast

7 Market Breakup by Indication

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 COPD
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adherium Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Aristopharma Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 AstraZeneca PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Baxter International Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boehringer Ingelheim International GmbH
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Cohero Health Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Koninklijke Philips N.V.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Omron Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pari Respiratory Equipment Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Recipharm AB
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Verona Pharma plc
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
  • Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2024
  • Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2024
  • Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2024
  • Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
  • Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
  • Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
  • Table 7: Global: COPD and Asthma Devices Market: Key Players